Home / Sweden / Oncopeptides AB

Oncopeptides AB

Short position disclosed on October 30, 2026.

1.48% of the capital sold short

2 disclosing funds

440 disclosures on record

SE0009414576 ISIN code

Evolution of the disclosed total

0%0.5%1%1.5%2%

2025-13-01Apr 2026Jul 2026Oct 2026

Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.

Over the whole history, the total peaked at 8.43% on August 19, 2021. The shaded band matches the twelve months of the first chart.

July 24, 2018 today

Open positions

The funds disclosing a short position that is still open.
Fund	Twelve months	% of capital	Over the year	Since
GSA Capital Partners LLP		0.88%	new	October 19, 2026
Two Sigma Investments, LP		0.60%	new	October 30, 2026

On the other side: the funds that hold Oncopeptides AB Titelia

Follow by RSS

Get the moves on Oncopeptides AB by mail, at most once a day.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

440 disclosures on record for this share.
Date	Fund	% of capital
October 22, 2021	Citadel Advisors LLC	1.30%
October 22, 2021	Adage Capital Management LP	0.66%
October 22, 2021	Mangrove Partners	0.00%
October 21, 2021	Qube Research & Technologies Limited	0.55%
October 19, 2021	Qube Research & Technologies Limited	0.66%
October 18, 2021	Citadel Advisors LLC	0.57%
October 15, 2021	Worldquant LLC	1.16%
October 14, 2021	Qube Research & Technologies Limited	0.78%
October 14, 2021	Citadel Advisors LLC	0.60%
October 13, 2021	Worldquant LLC	1.05%
October 13, 2021	Citadel Advisors LLC	0.57%
October 12, 2021	Worldquant LLC	0.92%
October 12, 2021	Citadel Advisors LLC	0.00%
October 11, 2021	Qube Research & Technologies Limited	0.89%
October 11, 2021	Worldquant LLC	0.80%
October 11, 2021	Mangrove Partners	0.73%
October 11, 2021	Citadel Advisors LLC	0.51%
October 8, 2021	Mangrove Partners	0.93%
October 8, 2021	Worldquant LLC	0.67%
October 8, 2021	Citadel Advisors LLC	0.00%
October 7, 2021	Qube Research & Technologies Limited	1.02%
October 7, 2021	Citadel Advisors LLC	0.70%
October 7, 2021	Marshall Wace LLP	0.00%
October 1, 2021	Arrowstreet Capital Limited Partnership	1.21%
September 30, 2021	Citadel Advisors LLC	0.00%
September 29, 2021	PDT Partners LLC	0.90%
September 28, 2021	Marshall Wace LLP	0.79%
September 20, 2021	Qube Research & Technologies Limited	0.67%
September 17, 2021	Mangrove Partners	1.10%
September 17, 2021	Qube Research & Technologies Limited	0.70%
September 17, 2021	Citadel Advisors LLC	0.59%
September 16, 2021	Qube Research & Technologies Limited	0.80%
September 16, 2021	Citadel Advisors LLC	0.67%
September 15, 2021	Qube Research & Technologies Limited	0.77%
September 14, 2021	Citadel Advisors LLC	0.74%
September 13, 2021	Mangrove Partners	1.00%
September 13, 2021	Qube Research & Technologies Limited	0.64%
September 10, 2021	Citadel Advisors LLC	0.82%
September 8, 2021	Arrowstreet Capital Limited Partnership	1.19%
September 8, 2021	Mangrove Partners	0.96%
September 7, 2021	Citadel Advisors LLC	0.76%
September 7, 2021	Consonance Capital Management LP	0.00%
September 2, 2021	Marshall Wace LLP	0.86%
September 2, 2021	Citadel Advisors LLC	0.81%
September 2, 2021	Qube Research & Technologies Limited	0.53%
August 31, 2021	Qube Research & Technologies Limited	0.00%
August 30, 2021	Qube Research & Technologies Limited	0.54%
August 27, 2021	Qube Research & Technologies Limited	0.00%
August 26, 2021	Qube Research & Technologies Limited	0.55%
August 24, 2021	Citadel Advisors LLC	1.06%

Download 440 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in Sweden

Samhällsbyggnadsbolaget i Norden AB 11.43% of the capital sold short
JM AB 7.91% of the capital sold short
Elekta AB (publ) 7.80% of the capital sold short
Truecaller AB 6.94% of the capital sold short
Intrum AB 6.22% of the capital sold short
Mips AB 5.30% of the capital sold short
Xvivo Perfusion Aktiebolag 5.11% of the capital sold short
Cibus Real Estate AB (publ) 4.66% of the capital sold short
Hemnet Group AB (publ) 4.59% of the capital sold short
Aktiebolaget Electrolux 4.58% of the capital sold short
Dynavox Group AB 4.31% of the capital sold short
RaySearch Laboratories AB (publ) 4.07% of the capital sold short

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Oncopeptides AB, source Finansinspektionen, data as at October 30, 2026, https://www.quivad.com/action/oncopeptides-ab?page=6